Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Mucocutaneous Lymph Node Syndrome

Known as: Acute febrile mucocutaneous lymph node syndrome, MLNS, Acute febrile mucocutaneous lymph node syndrome [MCLS] 
A vasculitis characterized by inflammation of the arteries, particularly the coronary arteries. The vasculitis may lead to aneurysm formation and… Expand
National Institutes of Health

Related topics

Related topics

17 relations
ArteritisCardiovascular systemIn BloodMalignant lymphoma, lymphocytic, intermediate differentiation, diffuse
Expand

Broader (3)

Dermatologic disordersPolyarteritis NodosaSyndrome

Narrower (1)

Infantile polyarteritis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
Importance In communities with high rates of coronavirus disease 2019, reports have emerged of children with an unusual syndrome… Expand
Review
2017
Review
2017
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Review
2013
Review
2013
So depression is an inflammatory disease, but where does the inflammation come from?
BackgroundWe now know that depression is associated with a chronic, low-grade inflammatory response and activation of cell… Expand
Highly Cited
2006
Highly Cited
2006
Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Background: Although an increased cancer risk in Peutz-Jeghers syndrome is established, data on the spectrum of tumors associated… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2004
Review
2004
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on…
Background—Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Review
2004
Review
2004
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on…
Background. Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
1996
Highly Cited
1996
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.
BACKGROUND The long-term consequences of the cardiovascular sequelae in Kawasaki disease remain uncertain. METHODS AND RESULTS… Expand
Highly Cited
1989
Highly Cited
1989
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.
A growth factor for vascular endothelial cells was identified in the media conditioned by bovine pituitary follicular cells and… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1975
Highly Cited
1975
Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.
In 1967, Kawasaki, in Japan, first described a new syndrome affecting infants and young children-an acute, febrile illness with… Expand
Highly Cited
1974
Highly Cited
1974
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.
What may be a new disease has been afflicting infants and young children in Japan since 1960. It is an acute, febrile… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE